260 related articles for article (PubMed ID: 14722073)
21. Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter.
Stossi F; Likhite VS; Katzenellenbogen JA; Katzenellenbogen BS
J Biol Chem; 2006 Jun; 281(24):16272-8. PubMed ID: 16608856
[TBL] [Abstract][Full Text] [Related]
22. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
Bentrem D; Dardes R; Liu H; MacGregor-Schafer J; Zapf J; Jordan V
Endocrinology; 2001 Feb; 142(2):838-46. PubMed ID: 11159857
[TBL] [Abstract][Full Text] [Related]
24. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.
Mazumdar A; Wang RA; Mishra SK; Adam L; Bagheri-Yarmand R; Mandal M; Vadlamudi RK; Kumar R
Nat Cell Biol; 2001 Jan; 3(1):30-7. PubMed ID: 11146623
[TBL] [Abstract][Full Text] [Related]
26. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1.
Wagner S; Weber S; Kleinschmidt MA; Nagata K; Bauer UM
J Biol Chem; 2006 Sep; 281(37):27242-50. PubMed ID: 16861234
[TBL] [Abstract][Full Text] [Related]
27. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications.
Meeran SM; Patel SN; Li Y; Shukla S; Tollefsbol TO
PLoS One; 2012; 7(5):e37748. PubMed ID: 22662208
[TBL] [Abstract][Full Text] [Related]
28. E6-AP facilitates efficient transcription at estrogen responsive promoters through recruitment of chromatin modifiers.
Catoe HW; Nawaz Z
Steroids; 2011 Aug; 76(9):897-902. PubMed ID: 21530567
[TBL] [Abstract][Full Text] [Related]
29. Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1.
Khaleque MA; Bharti A; Gong J; Gray PJ; Sachdev V; Ciocca DR; Stati A; Fanelli M; Calderwood SK
Oncogene; 2008 Mar; 27(13):1886-93. PubMed ID: 17922035
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.
Zhou Q; Atadja P; Davidson NE
Cancer Biol Ther; 2007 Jan; 6(1):64-9. PubMed ID: 17172825
[TBL] [Abstract][Full Text] [Related]
31. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
32. Gender matters: estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A).
Kalthoff S; Winkler A; Freiberg N; Manns MP; Strassburg CP
J Hepatol; 2013 Oct; 59(4):797-804. PubMed ID: 23714156
[TBL] [Abstract][Full Text] [Related]
33. Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR.
Palijan A; Fernandes I; Bastien Y; Tang L; Verway M; Kourelis M; Tavera-Mendoza LE; Li Z; Bourdeau V; Mader S; Yang XJ; White JH
J Biol Chem; 2009 Oct; 284(44):30264-74. PubMed ID: 19744931
[TBL] [Abstract][Full Text] [Related]
34. Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha.
Leong H; Sloan JR; Nash PD; Greene GL
Mol Endocrinol; 2005 Dec; 19(12):2930-42. PubMed ID: 16051668
[TBL] [Abstract][Full Text] [Related]
35. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins.
Sun JM; Spencer VA; Li L; Yu Chen H; Yu J; Davie JR
Exp Cell Res; 2005 Jan; 302(1):96-107. PubMed ID: 15541729
[TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.
De Amicis F; Zupo S; Panno ML; Malivindi R; Giordano F; Barone I; Mauro L; Fuqua SA; Andò S
Mol Endocrinol; 2009 Apr; 23(4):454-65. PubMed ID: 19147702
[TBL] [Abstract][Full Text] [Related]
37. The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains.
Choi YB; Ko JK; Shin J
J Biol Chem; 2004 Dec; 279(49):50930-41. PubMed ID: 15456770
[TBL] [Abstract][Full Text] [Related]
38. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions.
Miao F; Gonzalo IG; Lanting L; Natarajan R
J Biol Chem; 2004 Apr; 279(17):18091-7. PubMed ID: 14976218
[TBL] [Abstract][Full Text] [Related]
39. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
40. Estradiol (E2)- and tamoxifen (Tmx)-bound ER-alpha (ERα) interact differentially with histone deacetylases 1 and 3 (HDACs 1 and 3).
Sharma D; Liu Y; Uht RM
J Steroid Biochem Mol Biol; 2017 Nov; 174():128-132. PubMed ID: 28847748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
